Levosimendan, a novel Ca2+ sensitizer, activates the glibenclamide-sensitive K+ channel in rat arterial myocytes
Authors:
- Hisashi YokoshikiHYHisashi Yokoshiki
- Yasuhiro KatsubeYKYasuhiro Katsube
- Masanori SunagawaMSMasanori Sunagawa
- Nicholas SperelakisNSNicholas Sperelakis
- 1 August 1997
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 333 (2-3) , 249-259
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- Coronary Effects of Diadenosine Tetraphosphate Resemble Those of Adenosine in Anesthetized Pigs: Involvement of ATP-Sensitive Potassium ChannelsJournal of Cardiovascular Pharmacology, 1996
- A Family of Sulfonylurea Receptors Determines the Pharmacological Properties of ATP-Sensitive K+ ChannelsNeuron, 1996
- Systemic and Coronary Hemodynamic Actions and Left Ventricular Functional Effects of Levosimendan in Conscious DogsJournal of Cardiovascular Pharmacology, 1995
- Hemodynamic and neurohumoral effects of levosimedan, a new calcium sensitizer, at rest and during exercise in healthy menThe American Journal of Cardiology, 1995
- Nonendothelial‐derived nitric oxide activates the ATP‐sensitive K+ channel of vascular smooth muscle cellsFEBS Letters, 1994
- Activation of ATP-Sensitive K+ Channels by Cyclic AMP-Dependent Protein Kinase in Cultured Smooth Muscle Cells of Porcine Coronary ArteryBiochemical and Biophysical Research Communications, 1993
- Effect of ATP-sensitive K+ channel regulators on cystic fibrosis transmembrane conductance regulator chloride currents.Journal of General Physiology, 1992
- Vasodilator and inotropic drugs for the treatment of chronic heart failure: Distinguishing hype from hopeJACC, 1988
- Effects of Enalapril on Mortality in Severe Congestive Heart FailureNew England Journal of Medicine, 1987
- Effect of Vasodilator Therapy on Mortality in Chronic Congestive Heart FailureNew England Journal of Medicine, 1986